Cargando…

Dual effect of radiotherapy related concomitant cardiovascular diseases in non‐small cell lung cancer

BACKGROUND: Nowadays, cancer and cardiac diseases are two of the most causes of death, so cancer treatment‐related cardiac death cannot be ignored. For lung cancer, chest radiotherapy (RT) is essential, but the related cardiotoxicity has not been fully studied. METHODS: We reviewed the data of 11,45...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, You, Tian, Baoqing, Wu, Meng, Chen, Minxin, Chen, Dawei, Yu, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883436/ https://www.ncbi.nlm.nih.gov/pubmed/35754191 http://dx.doi.org/10.1002/cam4.4948

Ejemplares similares

Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study
por: Mo, You, et al.
Publicado: (2022)

The prognostic value of postoperative radiotherapy in right tumor for lung related death: based on SEER database and real-world data
por: Mo, You, et al.
Publicado: (2023)

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shang, Shijie, et al.
Publicado: (2021)

Postoperative Radiotherapy in Completely Resected IIIA-N2 Non-small Cell Lung Cancer: Quit or Not?
por: Chen, Yu, et al.
Publicado: (2023)

Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage III Non-Small Cell Lung Cancer
por: Wang, Ruiyang, et al.
Publicado: (2023)

Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer
por: Jing, Xuquan, et al.
Publicado: (2016)

The Effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis
por: Ma, Jia-Chun, et al.
Publicado: (2022)

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer
por: Zhang, Xiaoli, et al.
Publicado: (2017)

Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database
por: Chen, Deng, et al.
Publicado: (2021)

Sequential or concomitant chemotherapy with hypofractionated radiotherapy for locally advanced non-small cell lung cancer: a meta-analysis of randomized trials
por: Viani, Gustavo Arruda, et al.
Publicado: (2021)

Effectiveness of temozolomide combined with whole brain radiotherapy for non‐small cell lung cancer brain metastases
por: Zhu, Ying, et al.
Publicado: (2018)

Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2020)

Radiotherapy combined with immunotherapy: the dawn of cancer treatment
por: Zhang, Zengfu, et al.
Publicado: (2022)

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
por: Hu, Haoyue, et al.
Publicado: (2023)

Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer
por: Uitterhoeve, Apollonia LJ, et al.
Publicado: (2007)

Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis
por: Zhang, Lei, et al.
Publicado: (2022)

A molecular and staging model predicts survival in patients with resected non-small cell lung cancer
por: Liu, Lei, et al.
Publicado: (2018)

Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study
por: Hsu, Ping‐Chih, et al.
Publicado: (2019)

Monitor unit optimization in stereotactic body radiotherapy for small peripheral non-small cell lung cancer patients
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury
por: Zhang, Zengfu, et al.
Publicado: (2021)

Radiotherapy for patients with completely resected pathologic IIIA(N2) non–small-cell lung cancer: a retrospective analysis
por: Zhu, Ying, et al.
Publicado: (2019)

Precision radiotherapy for non-small cell lung cancer
por: Yang, Wen-Chi, et al.
Publicado: (2020)

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression
por: Chen, Rui-Lian, et al.
Publicado: (2018)

Impact of concomitant fibrates on immunotherapy outcomes for advanced non‐small cell lung cancer
por: Stokes, William A., et al.
Publicado: (2022)

Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG)
por: Okano, Naoko, et al.
Publicado: (2023)

Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis
por: Li, Shuling, et al.
Publicado: (2022)

Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer
por: Wang, Peiliang, et al.
Publicado: (2021)

Machine learning in non-small cell lung cancer radiotherapy: A bibliometric analysis
por: Zhang, Jiaming, et al.
Publicado: (2023)

Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer
por: Miao, Junjie, et al.
Publicado: (2017)

Role of Radiotherapy in Metastatic Non-Small Cell Lung Cancer
por: Faria, Sergio L.
Publicado: (2014)

The evolving role of radiotherapy in non-small cell lung cancer
por: Brown, Sean, et al.
Publicado: (2019)

Preoperative radiation may improve the outcomes of resectable IIIA/N2 non‐small‐cell lung cancer patients: A propensity score matching‐based analysis from surveillance, epidemiology, and end results database
por: Chen, Dawei, et al.
Publicado: (2018)

S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial
por: Yao, Lei, et al.
Publicado: (2015)

Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer
por: Wang, Peiliang, et al.
Publicado: (2021)

International consensus on radiotherapy in metastatic non-small cell lung cancer
por: Zhu, Zhengfei, et al.
Publicado: (2022)

Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer
por: Chen, Yuan-Yuan, et al.
Publicado: (2015)

Peripheral memory and naïve T cells in non-small cell lung cancer patients with lung metastases undergoing stereotactic body radiotherapy: predictors of early tumor response
por: Liu, Chao, et al.
Publicado: (2019)

Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade
por: Wang, Minglei, et al.
Publicado: (2023)

Corrigendum: Machine learning in non-small cell lung cancer radiotherapy: a bibliometric analysis
por: Zhang, Jiaming, et al.
Publicado: (2023)

Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy
por: Liu, Chao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_98rge1kh15gpejf03o7mnbvp95